Search Options Stock News and Analysis from Schaeffer's

Preliminary Late-Stage Study Boosts Eli Lilly Stock

https://www.schaeffersresearch.com/content/news/2024/08/20/preliminary-late-stage-study-boosts-eli-lilly-stock

8/20/2024 10:06 AM

Eli Lilly And Co (NYSE:LLY) announced today preliminary results from a late-stage study indicated the main ingredients Zepbound and Mounjaro of weight-loss drug tirzepatide reduced the risk of progre...

Options Bulls Target Eli Lilly Stock After Beat-and-Raise

https://www.schaeffersresearch.com/content/news/2024/08/08/options-bulls-target-eli-lilly-stock-after-beat-and-raise

8/8/2024 10:28 AM

Eli Lilly And Co (NYSE:LLY) surpassed top- and bottom-line expectations for the second quarter, and lifted its full-year revenue outlook by $3 billion amid strong sales of weight loss drug and diab...

More Records Highs for Eli Lilly Stock After Buyout

https://www.schaeffersresearch.com/content/news/2024/07/08/more-records-highs-for-eli-lilly-stock-after-buyout

7/8/2024 10:14 AM

Eli Lilly And Co (NYSE:LLY) announced earlier today it will acquire Morphic Holding (NASDAQ:MORF) for $3.2 billion in cash, expanding its inflammatory bowel disease (IBD) drug portfolio. In turn, th...

Inflation Data, Fed Decision Highlight Mixed Week

https://www.schaeffersresearch.com/content/news/2024/06/14/inflation-data-fed-decision-highlight-mixed-week

6/14/2024 1:25 PM

The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) marked record closes throughout the week, while the Dow Jones Industrial Average (DJIA) fared quite differently, finishing most daily sessions lowe...

FDA Nudge Sends Pharma Stock to Fresh Record Highs

https://www.schaeffersresearch.com/content/news/2024/06/11/fda-nudge-sends-pharma-stock-to-fresh-record-highs

6/11/2024 10:00 AM

Shares of Eli Lilly And Co (NYSE:LLY) are enjoying a 2.3% surge this morning, last seen trading near $885.10 on the back of news that the Food and Drug Administration (FDA) panel unanimously approve...

PEOPLE ALSO SEARCH FOR